Skip to main content

Closed

CLLS: Cellectis S.A. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-69.2%

ROIC-27.2%

Financially safe

Stretched

Debt / equity1.38×

Interest coverage-5.6×

Current ratio1.52×

Cellectis S.A.

CLLSNASDAQ Global Market·USD·Closed

Cellectis S.A.

CLLSNASDAQ·USD·Closed

$2.75

−3.51%

$2.75

−$0.10 (3.51%)

52W Range

9thpctl

Volume

0.40×avg

Mkt Cap

276.15MUSD

P/E

-4.2TTM

Div Yield

–ann

52W Range

9thpctl

Volume

0.40×avg

Market Cap

276.15MUSD

P/E Ratio

-4.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings